Overview

Bioequivalence Study of Sertraline 100 mg Tablet and ZOLOFT Following a 100 mg Dose in Healthy Subjects Under Fasting Conditions

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

- Objective: - To compare the rate and extent of absorption of Torrent Pharmaceuticals Limited, India, sertraline and Pfizer, Inc., USA (Zoloft) sertraline, administered as a 1X100 mg tablet, under fasted conditions. - Study Design: - Single-dose, open-label, randomized two-way crossover.

Phase:

Phase 1

Details

Lead Sponsor:

Torrent Pharmaceuticals Limited

Treatments:

Sertraline